Patents by Inventor Andrew T. Schaeffer

Andrew T. Schaeffer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10712283
    Abstract: A liquid holding liquid holding apparatus for insertion of a test device into a test liquid, the liquid holding apparatus having a) a liquid holding device for holding test liquid; and b) test liquid in the liquid holding device. The liquid holding device has a front wall and a rear wall. The upper section of the liquid holding device has an access section where the front wall can be detached from the rear wall to allow access for a test strip test device. At least a portion of the front wall is substantially transparent or translucent. The front wall is attached to the rear wall at the access section by a first lamination and the front wall is attached to the rear wall below the access section by a second lamination. The peel strength of the second lamination is greater than the peel strength of the first lamination.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: July 14, 2020
    Assignee: Quantimetrix
    Inventors: Monty S. Ban, Brian R. Fernandez, Andrew T. Schaeffer, Mina Ghadessi
  • Publication number: 20180052112
    Abstract: A liquid holding liquid holding apparatus for insertion of a test device into a test liquid, the liquid holding apparatus having a) a liquid holding device for holding test liquid; and b) test liquid in the liquid holding device. The liquid holding device has a front wall and a rear wall. The upper section of the liquid holding device has an access section where the front wall can be detached from the rear wall to allow access for a test strip test device. At least a portion of the front wall is substantially transparent or translucent. The front wall is attached to the rear wall at the access section by a first lamination and the front wall is attached to the rear wall below the access section by a second lamination. The peel strength of the second lamination is greater than the peel strength of the first lamination.
    Type: Application
    Filed: October 27, 2017
    Publication date: February 22, 2018
    Inventors: Monty S. Ban, Brian R. Fernandez, Andrew T. Schaeffer, Mina Ghadessi
  • Publication number: 20030219445
    Abstract: The present invention provides peptide-ligand conjugates containing a peptide, where a free form of the peptide is capable of displacing a second ligand specific for the peptide. The invention also provides a method of selecting a cell. The method includes the steps of contacting a cell population with a peptide-ligand conjugate, wherein the conjugate comprises a first ligand specific for a cell in the population conjugated to a peptide capable of displacing a second ligand specific for the peptide, thereby forming a cell-conjugate complex; contacting the peptide-ligand conjugate with the second ligand; and isolating the cell-conjugate complex. The method can further include the step of adding a free form of the peptide to release the cell from the complex. The invention additionally provides a method of diagnosing a condition using peptide-ligand conjugates.
    Type: Application
    Filed: September 25, 2002
    Publication date: November 27, 2003
    Applicant: Nexell Therapeutics, Inc.
    Inventors: Andrew T. Schaeffer, Janet Tseng-Law, Jeffrey R. Thornton
  • Publication number: 20030119070
    Abstract: The present invention provides peptide-ligand conjugates containing a peptide, where a free form of the peptide is capable of displacing a second ligand specific for the peptide. The invention also provides a method of selecting a cell. The method includes the steps of contacting a cell population with a peptide-ligand conjugate, wherein the conjugate comprises a first ligand specific for a cell in the population conjugated to a peptide capable of displacing a second ligand specific for the peptide, thereby forming a cell-conjugate complex; contacting the peptide-ligand conjugate with the second ligand; and isolating the cell-conjugate complex. The method can further include the step of adding a free form of the peptide to release the cell from the complex. The invention also provides a subpopulation of cells containing two or more specifically isolated cells and methods of isolating cell subpopulations. The invention additionally provides a method of diagnosing a condition using peptide-ligand conjugates.
    Type: Application
    Filed: July 29, 2002
    Publication date: June 26, 2003
    Applicant: Nexell Therapeutics, Inc.
    Inventors: Andrew T. Schaeffer, Janet Tseng-Law, Jeffrey R. Thornton, Dennis E. Van Epps